Back to top
more

Aerpio Pharmaceuticals, Inc. (ARPO)

(Delayed Data from NSDQ)

$1.04 USD

1.04
376,415

+0.01 (0.96%)

Updated May 3, 2019 04:13 PM ET

After-Market: $1.05 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Company News for May 29, 2020

by Zacks Equity Research

Companies In The News Are: ABIO, ARPO, LL, DLTR

Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (ARPO) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For May 26th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Strong Buy: Here's Why

by Zacks Equity Research

Aerpio Pharmaceuticals, Inc. (ARPO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Tirthankar Chakraborty headshot

New Strong Buy Stocks For May 21st

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (ARPO) Outperforming Other Medical Stocks This Year?

Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $0.63, marking a +1.69% move from the previous day.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for April 24th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aerpio Pharmaceuticals, Inc. (ARPO) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Aerpio Pharmaceuticals, Inc. (ARPO) closed at $0.72 in the latest trading session, marking a +0.61% move from the prior day.

Has Aerpio Pharmaceuticals (ARPO) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (ARPO) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For April 20th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Immunovant (IMVT) Catches Eye: Stock Jumps 5%

by Zacks Equity Research

Immunovant (IMVT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Aerpio Pharmaceuticals, Inc. (ARPO) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Aerpio Pharmaceuticals, Inc. (ARPO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

All You Need to Know About Aerpio Pharmaceuticals, Inc. (ARPO) Rating Upgrade to Buy

by Zacks Equity Research

Aerpio Pharmaceuticals, Inc. (ARPO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Aerpio Pharmaceuticals, Inc. (ARPO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Aerpio (ARPO) Jumps: Stock Rises 7.8%

by Zacks Equity Research

Aerpio (ARPO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Vertex (VRTX) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Vertex (VRTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.